Rhenman & Partners wins prestigious awards at the Nordic Hedge Awards: best overall 3-year and 5-year performance
The sector fund Rhenman Healthcare Equity L / S was awarded for the best overall performance among all the Nordic hedge funds at the Nordic Hedge Awards. The awards relate to overall performance over a period of three and five years.
The winning categories were ”Best Net Performance - 3 Years” as well as ”Best Net Performance - 5 Years”.
“We are extremely pleased to receive these awards. This is the most respected prize in the Nordic region for hedge funds, which clearly demonstrates our ability to generate substantial long-term value for our investors. To be the best hedge fund over both three and five years says more than to win it based on performance for a single year”, commented Carl Grevelius, Founding Partner and Head of Investor Relations.
"Our success depends largely on the managers’ close collaboration with the medical experts in our Scientific Advisory Board. Equally important is our focus on the healthcare sector, including pharmaceuticals, medical technology, biotechnology and service, which gives us a vast number of investment opportunities to choose from."
Earlier this year, the fund was awarded Long Term Performance - Equity Strategies (5 Years), referring to the period 2011-2015, at the prestigious EuroHedge Awards in London.
The Fund has an unprecedented return history since inception in June 2009. The main fund class, the IC1 (EUR), has risen 242% in total, corresponding to an average annual return of +20%. In 2015, the return was +20%. In accordance with the fund prospectus, the fund was closed to investments from new investors on December 31, 2015 when total assets under management reached €500m.
For more information, please contact:
Carl Grevelius, Founding Partner / Head of Investor Relations
Phone: +46 8 459 88 83
E-mail: carl@rhepa.com
www.rhepa.com
About Rhenman & Partners
Rhenman & Partners Asset Management is a Stockholm-based asset manager focusing on the healthcare sector. The company's AUM amounts to over EUR 530m (as per end of Dec, 2015). Rhenman & Partners was founded in 2008 by a trio with extensive experience of the asset management sector, as well as an unrivalled track record in the healthcare sector. The Investment Team is supported by a Scientific Advisory Board composed of eminent professors with access to a wide network of scientists and experts worldwide.
Tags: